# A Dose Response Study of UT-15C SR in Patients With Exercise-Induced Pulmonary Hypertension

> **NCT01104870** · PHASE2 · COMPLETED · sponsor: **United Therapeutics** · enrollment: 50 (actual)

## Conditions studied

- Pulmonary Hypertension

## Interventions

- **DRUG:** UT-15C

## Key facts

- **NCT ID:** NCT01104870
- **Lead sponsor:** United Therapeutics
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-04
- **Primary completion:** 2013-01
- **Final completion:** 2013-01
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2016-05-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01104870

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01104870, "A Dose Response Study of UT-15C SR in Patients With Exercise-Induced Pulmonary Hypertension". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01104870. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
